ArticleInfection and drug resistance2026
Article in Infection and drug resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Case Presentation: A HIV-positive patient subsequently developed TM pulmonary infection. Clinical symptoms and laboratory test results were non-specific. Imaging studies revealed pulmonary masses, and the patient was misdiagnosed with lung cancer outside the hospital, leading to an erroneous surgical resection. The patient did not improve postoperatively but instead developed high fever and persistent cough, with symptoms worsening. During treatment at our hospital, the patient was definitively diagnosed with TM lung infection, not lung cancer. Due to the rarity of TM infection and lack of experience, treatment was delayed, leading to worsening of the patient's condition. The patient exhibited gastrointestinal bleeding, progressive neurological dysfunction, hydrocephalus, and multi-organ dysfunction, which ultimately resulted in the death of the patient. Conclusion: TM infections often present with insidious onset, prolonged course, and lack of specific clinical symptoms, imaging findings, or laboratory test characteristics, making diagnosis challenging and frequently leading to misdiagnosis or missed diagnosis, resulting in high mortality rates. Therefore, clinicians should enhance their diagnostic and treatment experience regarding TM infections in HIV-positive individuals or populations in non-endemic regions, initiate pathogen culture and histopathological diagnosis as early as possible, and integrate the results of mNGS and mass spectrometry analysis to improve the detection rate and early diagnosis rate of TM infections. This will ensure that patients can receive timely and accurate treatment, which is crucial for improving their prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.